Robert Ruffolo
Angel · Massachusetts
Board director at 4 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jan 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Elucida OncologyJun 15, 2023
- SEC Form D: LB PharmaceuticalsSep 21, 2023
- SEC Form D: OcuTerra TherapeuticsDec 22, 2023
- SEC Form D: Elicio TherapeuticsJan 5, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.